Global Intranasal Drug Delivery Market 2014-2018: Key Vendors are Becton, Dickinson and Company, GlaxoSmithKline, Johnson & Johnson and Novartis
26 Aug, 2014, 17:49 BST
DUBLIN, Aug. 26, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Intranasal Drug Delivery Market 2014-2018" report to their offering.
Intranasal drug delivery system is a medical device used for the administration of drugs for the treatment of local diseases in the nose and paranasal sinus such as allergic and non-allergic rhinitis and sinusitis. The nose is considered to be an ideal administrative route for needle-free vaccination and systematic drug delivery.
Continuous technological advancement is being made in intranasal drug delivery product to achieve efficient treatment facility. Intranasal drug delivery system plays a major role in improving the quality of the life of patients, by providing an easy mode of drug administration for patients on long-term therapy, as well as low risk of overdose and enhanced bioavailability.
The analysts forecast the Global Intranasal Drug Delivery market to grow at a CAGR of 2.92 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Intranasal Drug Delivery market for the period 2014-2018. To calculate the market size, the report considers the revenue generated from the sales of the following intranasal drug delivery systems:
- Nasal spray
- Nasal drop
- Nasal powder
- Nasal gel
- Nasal vaccine
The report, the Global Intranasal Drug Delivery market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Intranasal Drug Delivery market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
One of the emerging trends that the market is likely to experience is an increasing adoption of non-invasive administration products. As non-invasive nasal drug delivery increases the compliance of the patient through their convenient application, they find more preference among end-users.
According to the report, one of the major drivers in the market is the increasing aging population. With growing age, people are more susceptible to developing respiratory diseases. Hence, that is an important factor in increasing the demand for intranasal drug delivery products in the market.
Further, the report states that one of the major challenges in the market is a risk of overdosing, which causes various side-effects.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Introduction
06. Market Landscape
07. Market Segmentation by Product
08. Geographical Segmentation
09. Buying Criteria
10. Market Growth Drivers
11. Drivers and their Impact
12. Market Challenges
13. Impact of Drivers and Challenges
14. Market Trends
15. Trends and their Impact
16. Vendor Landscape
17. Key Vendor Analysis
Companies Mentioned:
- Becton
- Dickinson and Company
- GlaxoSmithKline
- Johnson & Johnson
- Novartis
- Actiza Pharmaceutical
- Aptar Group
- Korten Pharmaceuticals
- OptiNose
- Patheon
- Vee Remedies
- Zymeth Wellness
For more information visit http://www.researchandmarkets.com/research/6nsnrd/global_intranasal
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
SOURCE Research and Markets